| Literature DB >> 34820545 |
Tulay Candan1, Muhammet Candan2, Cenk Eray Yildiz3, Mehmet Gumustas4, Selim Erenturk3, Yusuf Kenan Yalcinbas5.
Abstract
INTRODUCTION: Compromise of tissue oxygenation during surgery is associated with increased mortality and morbidity in the postoperative period in patients with congenital cardiac disorders. It may be monitored with near-infrared spectroscopy (NIRS). We aimed to evaluate the tissue oxygenation and factors which may affect it by bilateral cerebral and somatic NIRS levels during cardiopulmonary bypass and to compare the NIRS values of cyanotic and acyanotic patient groups.Entities:
Keywords: cardiopulmonary bypass; cerebral oxygenation; congenital cardiac surgery; near-infrared spectroscopy; somatic oxygenation
Year: 2020 PMID: 34820545 PMCID: PMC8609373 DOI: 10.5114/amsad.2020.103377
Source DB: PubMed Journal: Arch Med Sci Atheroscler Dis ISSN: 2451-0629
Figure 1A – Projection of the forehead – right and left frontal lobes of the patient. B – Lumbar projection – right and left renal region of the patient. C – Simultaneous measurement of bilateral cerebral and somatic NIRS with INVOS Cerebral/Somatic Oximeter (Medtronic, Somanetics, Covidien, Mansfield, MA 02048 USA)
Demographic features of the cyanotic patients
| Patient | Age | Gender | Height [cm] | Weight [kg] | Diagnosis | Operation | CC time [min] | CPB time [min] |
|---|---|---|---|---|---|---|---|---|
| 1 | 8 months | F | 59 | 5 | TOF, ASD, APCA | Total correction | 62 | 91 |
| 2 | 4 months | M | 60 | 5.3 | DORV | DORV correction | 40 | 62 |
| 3 | 6 months | F | 67 | 8 | Pulmonary atresia, RV + tricuspid hypoplasia | Glenn + atrial septectomy | 5 | 66 |
| 4 | 3 months | M | 53 | 4.3 | TGA, PFO, PH | Arterial switch | 159 | 286 |
| 5 | 1 year 3 months | M | 80 | 9 | TGA, VSD, PS, ASD | Rastelli | 122 | 148 |
| 6 | 3 years 3 months | M | 97 | 12.6 | TOF | Total correction | 126 | 150 |
| 7 | 21 days | M | 52 | 3.8 | TOF, VSD, ASD | Total correction | 59 | 83 |
| 8 | 1 year 5 months | M | 79 | 10.5 | VSD, PS | Total correction | 96 | 136 |
| 9 | 3 months | M | 62 | 5 | VSD, pulmonary atresia | Shunt + MAPCA bandung | 10 | 60 |
| 10 | 2.5 years | M | 100 | 15 | TGA, ASD, VSD | Senning + VSD closure | 57 | 225 |
| 11 | 3 years 6 months | M | 99 | 13.5 | TGA, VSD | Arterial switch | 153 | 249 |
| 12 | 6 months | F | 48 | 3 | VSD, PS | VSD closure, PS repair | 76 | 134 |
| 13 | 9 months | M | 68 | 8.5 | TOF | Total correction | 67 | 93 |
| 14 | 3 years | F | 102 | 15.7 | TGA, VSD, PS, ASD | Rastelli | 141 | 175 |
| 15 | 1 year 11 months | F | 81 | 9.2 | VSD, PS, LPA stenosis | Total correction | 54 | 83 |
CC – cross clamp, CPB – cardiopulmonary bypass, TOF – tetralogy of Fallot, ASD – atrial septal defect, APCA – aortopulmonary collateral, DORV – double outlet right ventricle, RV – right ventricle, TGA – transposition of great arteries, PFO – patent foramen ovale, PH – pulmonary hypertension, VSD – ventricular septal defect, PS – pulmonary stenosis, LPA – left pulmonary artery.
Demographic features of the acyanotic patients
| Patient | Age | Gender | Height [cm] | Weight [kg] | Diagnosis | Operation | CC time [min] | CPB time [min] |
|---|---|---|---|---|---|---|---|---|
| 1 | 3 years 4 months | M | 97 | 13 | ASD, PAPVD | ASD closure + PAPVD repair | 50 | 73 |
| 2 | 4 months | M | 61 | 6 | Bicuspid aortic valve, AO stenosis, ASD | Ross conno | 126 | 183 |
| 3 | 4 years | F | 103 | 15 | Aortic stenosis | Subaortic ridge resection | 126 | 148 |
| 4 | 10 months | F | 67 | 6 | VSD, PH | VSD closure | 39 | 60 |
| 5 | 3 months | F | 53 | 3.2 | ASD, VSD, operated PDA ligation | VSD + ASD closure | 51 | 69 |
| 6 | 4.5 months | M | 62 | 5.3 | VSD | VSD closure | 26 | 61 |
| 7 | 4.5 years | M | 113 | 20.5 | VSD | VSD closure | 77 | 127 |
| 8 | 5 years | F | 108 | 10.5 | MS, VSD, PH, PDA | VSD closure, PDA ligation, MI repair | 81 | 138 |
| 9 | 8 months 15 days | M | 70 | 6.5 | VSD, MI | VSD closure | 39 | 60 |
| 10 | 4 years | M | 111 | 18 | Partial AVSD, MI | Partial AVSD repair | 32 | 62 |
| 11 | 1 months | M | 50 | 3.5 | ASD, VSD, PDA, aort coarctation | PDA ligation, aorta coarctation repair + ASD, VSD closure | 84 | 216 |
| 12 | 2 years | F | 87 | 11 | Partial AVSD | Partial AVSD repair | 45 | 67 |
| 13 | 2 months | M | 60 | 4.7 | VSD, ASD | ASD + VSD closure | 43 | 78 |
| 14 | 2 yaears 11 months | F | 85 | 9.5 | Vascular ring, multiple VSD, operated banding | VSD + debanding | 91 | 126 |
| 15 | 4 years | F | 100 | 12 | Operated CAVSD, Left A-V valve insufficiency | Mitral valve repair | 42 | 60 |
CC – cross clamp, CPB – cardiopulmonary bypass, ASD – atrial septal defect, PH – pulmonary hypertension, VSD – ventricular septal defect, PAPVD – partial anomaly of pulmonary venous drainage, AO – aorta, PDA – patent ductus arteriosus, MS – mitral stenosis, MY – mitral insufficiency, AVSD – atrioventricular septal defect, CAVSD – complete atrioventricular septal defect, AV – atrioventricular.
Evaluation of left cerebral NIRS measurements
| Left cerebral | Cyanotic | Acyanotic | |||
|---|---|---|---|---|---|
| Median (Q1, Q3) | Median (Q1, Q3) | ||||
| T1 | 63 (50, 74) | 63 (58, 72) | 0.775 | ||
| T2 | 66 (56, 76) | 55 (47, 61) | 0.009 | ||
| T3 | 61 (56, 72) | 53 (44, 58) | 0.023 | ||
| T4 | 56 (48, 66) | 47.5 (44, 56) | 0.234 | ||
| ‡T5 | 59 (55, 67) | 60 (46, 60) | – | ||
| ‡T6 | 58.5 (49.5, 72.5) | 55 (55, 65) | – | ||
| TS | 60 (48, 67) | 51 (44, 55) | 0.074 | ||
|
| 0.081 | 0.007 |
| ||
|
|
|
|
| ||
| T2-T1 | 3 (–3, 9) | 0.928 | –8 (–17, 0) | 0.063 | 0.002 |
| T3-T1 | 5 (–2, 11) | 0.999 | –11 (–17, –4) | 0.028 | 0.004 |
Mann-Whitney U test,
Friedman test,
Bonferroni corrected Wilcoxon ranks test, Q1: 25% quarter, Q3: 75% quarter,
p < 0.05,
p < 0.01.
Figure 2Left cerebral NIRS values
Evaluation of right cerebral NIRS measurements
| Right cerebral | Cyanotic | Acyanotic | |||
|---|---|---|---|---|---|
| Median (Q1, Q3) | Median (Q1, Q3) | ||||
| T1 | 61 (46, 75) | 66 (57, 72) | 0.389 | ||
| T2 | 68 (53, 72) | 54 (47, 62) | 0.005 | ||
| T3 | 61 (50, 66) | 52 (46, 55) | 0.011 | ||
| T4 | 53 (45, 65) | 50.5 (47, 58) | 0.354 | ||
| ‡T5 | 61.5 (55, 69) | 50 (42, 51) | – | ||
| ‡T6 | 63 (53, 69) | 56 (53, 60) | – | ||
| TS | 56 (47, 69) | 50 (47, 56) | 0.116 | ||
|
| 0.001 | < 0.001 |
| ||
|
|
|
|
| ||
| T2-T1 | 6 (–3, 9) | 0.776 | –9 (–16, –3) | 0.007 | < 0.001 |
| T3-T1 | 3 (–5, 12) | 0.999 | –13 (–17, –6) | 0.012 | 0.001 |
Mann-Whitney U test,
Friedman test,
Bonferroni corrected Wilcoxon ranks test, Q1: 25% quarter, Q3: 75% quarter,
p < 0.05,
p < 0.01.
Figure 3Right cerebral NIRS values
Evaluation of left somatic measurements according to groups
| Left somatic | Cyanotic | Acyanotic | |||
|---|---|---|---|---|---|
| Median (Q1, Q3) | Median (Q1, Q3) | ||||
| T1 | 70 (62, 80) | 78 (66, 84) | 0.174 | ||
| T2 | 74 (68, 79) | 74 (70, 81) | 0.902 | ||
| T3 | 79 (73, 88) | 81 (73, 89) | 0.806 | ||
| T4 | 81 (72, 93) | 78 (68, 85) | 0.252 | ||
| 83.5 (78, 95) | 89 (84, 90) | – | |||
| 86 (77, 95) | 85 (84, 89) | – | |||
| TS | 78 (76, 91) | 76 (68, 84) | 0.161 | ||
|
| < 0.001 | 0.317 |
| ||
|
|
|
|
| ||
| T2-T1 | 1 (–9, 11) | 0.999 | 2 (–13, 5) | 0.999 | 0.624 |
| T3-T1 | 7 (4, 17) | 0.114 | 8 (–2, 10) | 0.515 | 0.486 |
| T4-T1 | 14 (6, 19) | 0.041 | 5.5 (–10, 11) | 0.999 | 0.063 |
| TS-T1 | 9 (4, 20) | 0.011 | 1 (–10, 14) | 0.999 | 0.106 |
| T3-T2 | 7 (0, 12) | 0.076 | 6 (–5, 14) | 0.723 | 0.683 |
| T4-T2 | 11 (3, 20) | 0.037 | 3.5 (–6, 11) | 0.999 | 0.102 |
| TS-T2 | 9 (–1, 19) | 0.230 | 4 (–10, 12) | 0.999 | 0.202 |
| T4-T3 | 2 (–1, 12) | 0.999 | –0.5 (–12, 5) | 0.999 | 0.158 |
| TS-T3 | 0 (–4, 3) | 0.999 | –2 (–12, 5) | 0.999 | 0.305 |
| TS-T4 | 0 (–10, 0) | 0.999 | 0 (0, 0) | 0.999 | 0.652 |
Because of the number of cases, it was excluded from the evaluation and used only for information purposes.
Mann-Whitney U test,
Friedman test,
Bonferroni corrected Wilcoxon ranks test, Q1: 25% quarter, Q3: 75% quarter,
p < 0.05,
p < 0.01.
Figure 4Left somatic distribution in groups according to time
Evaluation of right somatic measurements according to groups
| Right somatic | Cyanotic | Acyanotic | |||
|---|---|---|---|---|---|
| Median (Q1, Q3) | Median (Q1, Q3) | ||||
| T1 | 68 (61, 79) | 79 (66, 83) | 0.233 | ||
| T2 | 71 (65, 79) | 74 (70, 78) | 0.595 | ||
| T3 | 76 (72, 88) | 78 (71, 91) | 0.744 | ||
| T4 | 84 (73, 91) | 75 (60, 90) | 0.270 | ||
| 87.5 (73, 95) | 90 (86, 91) | – | |||
| 82 (73, 95) | 86 (83, 89) | – | |||
| TS | 82 (71, 88) | 72 (69, 85) | 0.250 | ||
|
| 0.001 | 0.115 |
| ||
|
|
| ||||
| T2-T1 | 0 (–9, 20) | 0.999 | –2 (–10, 6) | 0.999 | 0.713 |
| T3-T1 | 7 (1, 20) | 0.325 | 7 (–4, 11) | 0.775 | 0.412 |
| T4-T1 | 12 (3, 25) | 0.082 | 6.5 (–23, 11) | 0.999 | 0.077 |
| TS-T1 | 9 (1, 19) | 0.023 | 5 (–13, 12) | 0.999 | 0.161 |
| T3-T2 | 6 (0, 13) | 0.184 | 5 (–1, 9) | 0.307 | 0.713 |
| T4-T2 | 11 (3, 21) | 0.134 | 3.5 (–8, 8) | 0.999 | 0.085 |
| TS-T2 | 11 (1, 17) | 0.308 | 5 (–8, 8) | 0.999 | 0.089 |
| T4-T3 | 1 (–1, 7) | 0.999 | –1 (–16, 4) | 0.999 | 0.158 |
| TS-T3 | 0 (–7, 2) | 0.999 | –3 (–11, 3) | 0.860 | 0.202 |
| TS-T4 | 0 (–5, 0) | 0.999 | 0 (–1, 0) | 0.999 | 0.847 |
Because of the number of cases, it was excluded from the evaluation and used only for information purposes.
Mann-Whitney U test,
Friedman test,
Bonferroni corrected Wilcoxon ranks test, Q1: 25% quarter, Q3: 75% quarter,
p < 0.05,
p < 0.01.
Figure 5Right somatic distribution in groups according to time